                         SEQUENCE LISTING

<110>  Board of Regents, The University of Texas System
 
<120>  MYELOID-DERIVED SUPPRESSOR CELL-SPECIFIC PEPTIDES FOR DIAGNOSTIC 
       AND THERAPEUTIC USE

<130>  UTFC.P1163WO

<140>  not yet known
<141>  2014-09-30

<150>  US 61/884,581
<151>  2013-09-30

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Trp Gly Trp Ser Leu Ser His Gly Tyr Gln Val Lys 
1               5                   10          


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Met Glu Trp Ser Leu Glu Lys Gly Tyr Thr Ile Lys 
1               5                   10          


<210>  3
<211>  310
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  3

Met Tyr Arg Met Gln Leu Leu Ser Cys Ile Ala Leu Ser Leu Ala Leu 
1               5                   10                  15      


Val Thr Asn Ser His His His His His His Val Val Pro Phe Tyr Ser 
            20                  25                  30          


His Ser Trp Gly Trp Ser Leu Ser His Gly Tyr Gln Val Lys Gly Gly 
        35                  40                  45              


Gly Ser Ala Glu Thr Val Glu Gly Gly Gly Gly Ser Gly Gly Gly Gly 
    50                  55                  60                  


Ser Gly Gly Gly Gly Ser Arg Ser Pro Ser Gly Pro Ile Ser Thr Ile 
65                  70                  75                  80  


Asn Pro Cys Pro Pro Cys Lys Glu Cys His Lys Cys Pro Ala Pro Asn 
                85                  90                  95      


Leu Glu Gly Gly Pro Ser Val Phe Ile Phe Pro Pro Asn Ile Lys Asp 
            100                 105                 110         


Val Leu Met Ile Ser Leu Thr Pro Lys Val Thr Cys Val Val Val Asp 
        115                 120                 125             


Val Ser Glu Asp Asp Pro Asp Val Gln Ile Ser Trp Phe Val Asn Asn 
    130                 135                 140                 


Val Glu Val His Thr Ala Gln Thr Gln Thr His Arg Glu Asp Tyr Asn 
145                 150                 155                 160 


Ser Thr Ile Arg Val Val Ser Thr Leu Pro Ile Gln His Gln Asp Trp 
                165                 170                 175     


Met Ser Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu Pro 
            180                 185                 190         


Ser Pro Ile Glu Arg Thr Ile Ser Lys Ile Lys Gly Leu Val Arg Ala 
        195                 200                 205             


Pro Gln Val Tyr Ile Leu Pro Pro Pro Ala Glu Gln Leu Ser Arg Lys 
    210                 215                 220                 


Asp Val Ser Leu Thr Cys Leu Val Val Gly Phe Asn Pro Gly Asp Ile 
225                 230                 235                 240 


Ser Val Glu Trp Thr Ser Asn Gly His Thr Glu Glu Asn Tyr Lys Asp 
                245                 250                 255     


Thr Ala Pro Val Leu Asp Ser Asp Gly Ser Tyr Phe Ile Tyr Ser Lys 
            260                 265                 270         


Leu Asn Met Lys Thr Ser Lys Trp Glu Lys Thr Asp Ser Phe Ser Cys 
        275                 280                 285             


Asn Val Arg His Glu Gly Leu Lys Asn Tyr Tyr Leu Lys Lys Thr Ile 
    290                 295                 300                 


Ser Arg Ser Pro Gly Lys 
305                 310 


<210>  4
<211>  310
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  4

Met Tyr Arg Met Gln Leu Leu Ser Cys Ile Ala Leu Ser Leu Ala Leu 
1               5                   10                  15      


Val Thr Asn Ser His His His His His His Val Val Pro Phe Tyr Ser 
            20                  25                  30          


His Ser Met Glu Trp Ser Leu Glu Lys Gly Tyr Thr Ile Lys Gly Gly 
        35                  40                  45              


Gly Ser Ala Glu Thr Val Glu Gly Gly Gly Gly Ser Gly Gly Gly Gly 
    50                  55                  60                  


Ser Gly Gly Gly Gly Ser Arg Ser Pro Ser Gly Pro Ile Ser Thr Ile 
65                  70                  75                  80  


Asn Pro Cys Pro Pro Cys Lys Glu Cys His Lys Cys Pro Ala Pro Asn 
                85                  90                  95      


Leu Glu Gly Gly Pro Ser Val Phe Ile Phe Pro Pro Asn Ile Lys Asp 
            100                 105                 110         


Val Leu Met Ile Ser Leu Thr Pro Lys Val Thr Cys Val Val Val Asp 
        115                 120                 125             


Val Ser Glu Asp Asp Pro Asp Val Gln Ile Ser Trp Phe Val Asn Asn 
    130                 135                 140                 


Val Glu Val His Thr Ala Gln Thr Gln Thr His Arg Glu Asp Tyr Asn 
145                 150                 155                 160 


Ser Thr Ile Arg Val Val Ser Thr Leu Pro Ile Gln His Gln Asp Trp 
                165                 170                 175     


Met Ser Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu Pro 
            180                 185                 190         


Ser Pro Ile Glu Arg Thr Ile Ser Lys Ile Lys Gly Leu Val Arg Ala 
        195                 200                 205             


Pro Gln Val Tyr Ile Leu Pro Pro Pro Ala Glu Gln Leu Ser Arg Lys 
    210                 215                 220                 


Asp Val Ser Leu Thr Cys Leu Val Val Gly Phe Asn Pro Gly Asp Ile 
225                 230                 235                 240 


Ser Val Glu Trp Thr Ser Asn Gly His Thr Glu Glu Asn Tyr Lys Asp 
                245                 250                 255     


Thr Ala Pro Val Leu Asp Ser Asp Gly Ser Tyr Phe Ile Tyr Ser Lys 
            260                 265                 270         


Leu Asn Met Lys Thr Ser Lys Trp Glu Lys Thr Asp Ser Phe Ser Cys 
        275                 280                 285             


Asn Val Arg His Glu Gly Leu Lys Asn Tyr Tyr Leu Lys Lys Thr Ile 
    290                 295                 300                 


Ser Arg Ser Pro Gly Lys 
305                 310 


